Last reviewed · How we verify
HPA, ANS stimulation
HPA, ANS stimulation is a Small molecule drug developed by University of Texas at Austin. It is currently FDA-approved. Also known as: vivarin, cortef.
HPA stimulation activates the hypothalamic-pituitary-adrenal axis to enhance sympathetic nervous system activity and stress hormone release.
Researchers have studied the effects of HPA and ANS stimulation on anxiety through clinical trials, comparing these interventions to a placebo. The HPA and ANS systems are protein-based, as indicated by their modality classification in ChEMBL.
At a glance
| Generic name | HPA, ANS stimulation |
|---|---|
| Also known as | vivarin, cortef |
| Sponsor | University of Texas at Austin |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
The hypothalamic-pituitary-adrenal (HPA) axis is a central neuroendocrine system that regulates stress responses through release of corticotropin-releasing hormone, adrenocorticotropic hormone, and cortisol. Stimulation of this axis via ANS (autonomic nervous system) activation increases sympathetic tone and glucocorticoid secretion, which can modulate immune function, metabolism, and cardiovascular responses. This mechanism may be leveraged therapeutically in conditions where enhanced stress hormone signaling or sympathetic activation is beneficial.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HPA, ANS stimulation CI brief — competitive landscape report
- HPA, ANS stimulation updates RSS · CI watch RSS
- University of Texas at Austin portfolio CI
Frequently asked questions about HPA, ANS stimulation
What is HPA, ANS stimulation?
How does HPA, ANS stimulation work?
Who makes HPA, ANS stimulation?
Is HPA, ANS stimulation also known as anything else?
What development phase is HPA, ANS stimulation in?
Related
- Manufacturer: University of Texas at Austin — full pipeline
- Also known as: vivarin, cortef
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing